HighTower Advisors
CTSO icon

HighTower Advisors’s Cytosorbents Corp CTSO Stock Holding History

HighTower Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,229
Closed -$99K – 3329
2021
Q3 		$99K Buy
12,229
+464
+4% +$3.77K ﹤0.01% 2847
2021
Q2 		$89K Buy
11,765
+346
+3% +$2.92K ﹤0.01% 2826
2021
Q1 		$102K Buy
+11,419
New +$109K ﹤0.01% 2755

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors's CTSO Position: Q4 2021 in Review

HighTower Advisors sold out of Cytosorbents Corp (CTSO) in Q4 2021, closing a stake of 12,229 shares — an estimated $99K sold.

HighTower Advisors first reported a position in CTSO in Q1 2021 and held it in 3 quarters. The position peaked at $102K in Q1 2021. 91 funds tracked by Wall St. Rank hold CTSO as of Q4 2021.

  • HighTower Advisors reported no remaining Cytosorbents Corp position as of Q4 2021 after selling out during the quarter.
  • HighTower Advisors sold 12,229 Cytosorbents Corp shares in Q4 2021, an estimated $99K.
  • HighTower Advisors first reported a position in Cytosorbents Corp in Q1 2021 and held it in 3 quarters.
  • HighTower Advisors's Cytosorbents Corp position peaked at $102K in Q1 2021.
  • 91 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2021.

Based on HighTower Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.